Skip to main content
. 2020 May 28;17(11):3829. doi: 10.3390/ijerph17113829

Table 1.

Different characteristics of co-morbidities between the study and control group.

Baseline Characteristics Study
N = 6076
Control
N = 24,304
p Value
Age 1.0000
<40 2283 (37.57%) 9132 (37.57%)
40–59 2637 (43.4%) 10,548 (43.4%)
60–79 1102 (18.14%) 4408 (18.14%)
≥80 54 (0.89%) 216 (0.89%)
Gender 1.0000
Male 3914 (64.42%) 15,656 (64.42%)
Female 2162 (35.58%) 8648 (35.58%)
Co-morbidities
Hypertension 1597 (26.28%) 5362 (22.06%) <0.0001
Diabetes mellitus 797 (13.12%) 2681 (11.03%) <0.0001
Ischemic heart disease 592 (9.74%) 1812 (7.46%) <0.0001
Hyperlipidemia 1403 (23.09%) 4443 (18.28%) <0.0001
Heart failure 214 (3.52%) 645 (2.65%) 0.0003
Peripheral vascular disease 159 (2.62%) 479 (1.97%) 0.0017
Cerebrovascular disease 410 (6.75%) 1307 (5.38%) <0.0001
Dementia 34 (0.56%) 152 (0.63%) 0.5563
Chronic pulmonary diseases 1664 (27.39%) 3833 (15.77%) <0.0001
Rheumatic disease 138 (2.27%) 377 (1.55%) 0.0001
Peptic ulcer disease 1780 (29.3%) 5177 (21.3%) <0.0001
Liver disease 1536 (25.28%) 4519 (18.59%) <0.0001
Hemiplegia or paraplegia 41 (0.67%) 227 (0.93%) 0.0533
Keratopathy 424 (6.98%) 1277 (5.25%) <0.0001
Uveitis 56 (0.92%) 158 (0.65%) 0.0236
Glaucoma 120 (1.97%) 335 (1.38%) 0.0006
AMD 51 (0.84%) 141 (0.58%) 0.0226

AMD = age-related macular degeneration.